Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
AIDS (London, England)|June 8, 2021
Survival following screening and preemptive antifungal therapy for subclinical cryptococcal disease in advanced HIV infectionTariro Azure Makadzange, Admire Hlupeni, Rhoderick Machekano, et al.Plos One|September 23, 2021
Adverse outcomes after partner bereavement in people with reduced kidney function: Parallel cohort studies in England and DenmarkPatrick Bidulka, Søren Viborg Vestergaard, Admire Hlupeni, et al.Trials|January 16, 2019
Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority TrialDavid S Lawrence, Nabila Youssouf, Síle F Molloy, et al.Trials|November 25, 2018
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority TrialDavid S Lawrence, Nabila Youssouf, Síle F Molloy, et al.Journal of the International AIDS Society|June 6, 2025
Household economic impact of HIV-associated cryptococcal meningitis in five countries in Southern and Eastern AfricaDavid S Lawrence, Charles Muthoga, Jack Adams, et al.The Lancet. Global Health|November 18, 2022
Cost-effectiveness of single, high-dose, liposomal amphotericin regimen for HIV-associated cryptococcal meningitis in five countries in sub-Saharan Africa: an economic analysis of the AMBITION-cm trialDavid S Lawrence, Charles Muthoga, David B Meya, et al.BMJ Open|April 4, 2019
AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence studyPonego Lloyd Ponatshego, David Stephen Lawrence, Nabila Youssouf, et al.The New England Journal of Medicine|March 23, 2022
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal MeningitisJoseph N Jarvis, David S Lawrence, David B Meya, et al.Pageof 2